Cargando…

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)

BACKGROUND: The imposition of restrictions on social mixing early in the COVID-19 pandemic was followed by a reduction in asthma exacerbations in multiple settings internationally. Temporal trends in social mixing, incident acute respiratory infections (ARI) and asthma exacerbations following relaxa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tydeman, Florence, Pfeffer, Paul E, Vivaldi, Giulia, Holt, Hayley, Talaei, Mohammad, Jolliffe, David, Davies, Gwyneth, Lyons, Ronan A, Griffiths, Christopher, Kee, Frank, Sheikh, Aziz, Shaheen, Seif O, Martineau, Adrian R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2023
Materias:	Asthma
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359556/ https://www.ncbi.nlm.nih.gov/pubmed/36423925 http://dx.doi.org/10.1136/thorax-2022-219591

Ejemplares similares

Risk factors for SARS-CoV-2 infection after primary vaccination with ChAdOx1 nCoV-19 or BNT162b2 and after booster vaccination with BNT162b2 or mRNA-1273: A population-based cohort study (COVIDENCE UK)
por: Vivaldi, Giulia, et al.
Publicado: (2022)

Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)
por: Jolliffe, David A., et al.
Publicado: (2022)

Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data
por: Shah, Syed A, et al.
Publicado: (2021)

Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
por: Holt, Hayley, et al.
Publicado: (2023)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)
por: Talaei, Mohammad, et al.
Publicado: (2022)

Influence of HIV status on the management of acute asthma exacerbations
por: Adrish, Muhammad, et al.
Publicado: (2019)

Relationship between asthma and severe COVID-19: a national cohort study
por: Dolby, Ted, et al.
Publicado: (2023)

Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations
por: Chan, Rory, et al.
Publicado: (2022)

Asthma exacerbations are associated with a decline in lung function: a longitudinal population-based study
por: Soremekun, Seyi, et al.
Publicado: (2023)

Once-daily fluticasone furoate (FF)/vilanterol reduces risk of severe exacerbations in asthma versus FF alone
por: Bateman, Eric D, et al.
Publicado: (2014)

Core outcomes and factors influencing the experience of care for children with severe acute exacerbations of asthma: a qualitative study
por: Craig, Simon, et al.
Publicado: (2023)

International perspective on research priorities and outcome measures of importance in the care of children with acute exacerbations of asthma: a qualitative interview study
por: Gray, Charmaine S, et al.
Publicado: (2023)

Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT)
por: Jolliffe, David A, et al.
Publicado: (2022)

Sociodemographic factors associated with time to discharge for hospitalised patients with asthma and asthma exacerbation using the Ghana Health Service District Information Management System 2 (DHIMS-2) database, 2012–2017
por: Narh, Clement T, et al.
Publicado: (2021)

Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era
por: Jackson, David J, et al.
Publicado: (2021)

Persistent variations in national asthma mortality, hospital admissions and prevalence by socioeconomic status and region in England
por: Gupta, Ramyani P, et al.
Publicado: (2018)

Systemic adverse effects from inhaled corticosteroid use in asthma: a systematic review
por: Patel, Roshni, et al.
Publicado: (2020)

Impact of COVID-19 on people with asthma: a mixed methods analysis from a UK wide survey
por: Philip, Keir Elmslie James, et al.
Publicado: (2022)

At-risk children with asthma (ARC): a systematic review
por: Buelo, Audrey, et al.
Publicado: (2018)

Early Exacerbation Relapse is Increased in Patients with Asthma and Bronchiectasis (a Post hoc Analysis)
por: Hill, Andrew R., et al.
Publicado: (2023)

uPAR regulates bronchial epithelial repair in vitro and is elevated in asthmatic epithelium
por: Stewart, Ceri E, et al.
Publicado: (2011)

Risk factors for atopic and non-atopic asthma in a rural area of Ecuador
por: Moncayo, Ana Lucia, et al.
Publicado: (2010)

Refractory asthma in the UK: cross-sectional findings from a UK multicentre registry
por: Heaney, Liam G, et al.
Publicado: (2010)

Quantitative analysis of high-resolution computed tomography scans in severe asthma subphenotypes
por: Gupta, Sumit, et al.
Publicado: (2010)

Adverse effects of salmeterol in asthma: a neuronal perspective
por: Lommatzsch, M, et al.
Publicado: (2009)

Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β(2) agonist vilanterol administered once daily for 52 weeks in patients ≥12 years old with asthma: a randomised trial
por: Busse, William W, et al.
Publicado: (2013)

Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction
por: Lazarinis, Nikolaos, et al.
Publicado: (2014)

Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848
por: Delaney, Stephen, et al.
Publicado: (2016)

Three-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial use
por: Pilcher, Janine, et al.
Publicado: (2015)

Economic analysis of temperature-controlled laminar airflow (TLA) for the treatment of patients with severe persistent allergic asthma
por: Brazier, Peter, et al.
Publicado: (2016)

Effects of body mass index, tobacco smoking, alcohol drinking and solid fuel use on the risk of asthma: Individual Participant Data (IPD) meta-analysis of 175 000 individuals from 51 nationally representative surveys
por: Patra, Jayadeep, et al.
Publicado: (2016)

Factors associated with relapse in adult patients discharged from the emergency department following acute asthma: a systematic review
por: Hill, Jesse, et al.
Publicado: (2017)

Step 4: stick or twist? A review of asthma therapy
por: Slater, Mariel G, et al.
Publicado: (2016)

What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective
por: Howard, Sam, et al.
Publicado: (2016)

Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
por: Choi, Sanghun, et al.
Publicado: (2017)

Sputum colour can identify patients with neutrophilic inflammation in asthma
por: Pabreja, Kavita, et al.
Publicado: (2017)

Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
por: Kerkhof, Marjan, et al.
Publicado: (2018)

Concordance of opinions between patients and physicians and their relationship with symptomatic control and future risk in patients with moderate–severe asthma
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2017)

Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma
por: Fingleton, James, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qr9ibl1h3hvlru77mf1pe6nru9